Transcripts 202 and 205 of IL-6 confer resistance to Vemurafenib by reactivating the MAPK pathway in BRAF(V600E) mutant melanoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transcripts 202 and 205 of IL-6 confer resistance to Vemurafenib by reactivating the MAPK pathway in BRAF(V600E) mutant melanoma cells

Published:2020-05 Issue:2 Volume:390 Page:111942
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Zhao Kun,Lu Yanrong,Chen Younan,Cheng Jingqiu,Zhang Wengeng

Funder

National Key Development Plan for Precision Medicine Research

Science & Technology Department of Sichuan Province

Chengdu Science and Technology Program Projects

West China Hospital, Sichuan University

Publisher

Elsevier BV

Subject

Cell Biology

Reference29 articles.

1. Genomic classification of cutaneous melanoma;Network;Cell,2015

2. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

3. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

4. From genes to drugs: targeted strategies for melanoma;Flaherty;Nat. Rev. Canc.,2012

5. A landscape of driver mutations in melanoma;Hodis;Cell,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers;Cancer Cell International;2024-05-31

2. Clonal differences underlie variable responses to sequential and prolonged treatment;Cell Systems;2024-03

3. Clonal differences underlie variable responses to sequential and prolonged treatment;2023-03-25

4. Genome-Wide Scans and Transcriptomic Analyses Characterize Selective Changes as a Result of Chlorantraniliprole Resistance in Plutella xylostella;International Journal of Molecular Sciences;2022-10-13

5. Biofabrication of a Tri-layered 3D-Bioprinted CSC-based Malignant Melanoma Model for Personalized Cancer Treatment;Biofabrication;2022-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3